Effects of the renin angiotensin system on vasculogenesis-related progenitor cells

Current Opinion in Pharmacology

Volumn 11, Issue 2, 2011, Pages 162-174

  Roks, Anton Jm ^a   Rodgers, Kathy ^b   Walther, Thomas ^c,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF HULL   (United Kingdom)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ACETYLSALICYLIC ACID; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; CANDESARTAN; CD133 ANTIGEN; CD34 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INDAPAMIDE; LOSARTAN; METFORMIN; OLMESARTAN; PERINDOPRIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLACEBO; RAMIPRIL; RAMIPRILAT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SIMVASTATIN; STROMAL CELL DERIVED FACTOR 1; TELMISARTAN; TRANDOLAPRILAT; TXA 127; ULEX EUROPAEUS AGGLUTININ; UNCLASSIFIED DRUG; VALSARTAN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ACUTE CORONARY SYNDROME; ANGIOGENESIS; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DRUG TARGETING; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HEMATOPOIESIS; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; LIMB ISCHEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SENESCENCE; STEM CELL; THROMBOCYTOPENIA; TISSUE REGENERATION; VASCULOGENESIS RELATED PROGENITOR CELL;

EID: 79954418769     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2011.01.002     Document Type: Review

References (85)

1. E.T. Zambidis, T.S. Park, W. Yu, A. Tam, M. Levine, X. Yuan, M. Pryzhkova, and B. Péault Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells Blood 112 2008 3601 3614
2. K.M. Vogeli, S.W. Jin, G.R. Martin, and D.Y. Stainier A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula Nature 443 2006 337 339 (Pubitemid 44435152)
3. C. Qian, R.G. Schoemaker, W.H. van Gilst, and A.J. Roks The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function Clin Sci (Lond) 116 2009 301 314
4. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, and J.M. Isner Isolation of putative progenitor endothelial cells for angiogenesis Science 275 1997 964 967 (Pubitemid 27087709)
5. A.H. Kumar, and N.M. Caplice Clinical potential of adult vascular progenitor cells Arterioscler Thromb Vasc Biol 30 2010 1080 1087
6. M.R. Richardson, and M.C. Yoder Endothelial progenitor cells: Quo Vadis? J Mol Cell Cardiol 50 2011 266 272
7. J.C. Boisset, W. van Cappellen, C. Andrieu-Soler, N. Galjart, E. Dzierzak, and C. Robin In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium Nature 464 2010 116 120
8. J. Sainz, A. Al Haj Zen, G. Caligiuri, C. Demerens, D. Urbain, M. Lemitre, and A. Lafont Isolation of "side population" progenitor cells from healthy arteries of adult mice Arterioscler Thromb Vasc Biol 26 2006 281 286 (Pubitemid 43732188)
9. E. Zengin, F. Chalajour, U.M. Gehling, W.D. Ito, H. Treede, H. Lauke, J. Weil, H. Reichenspurner, N. Kilic, and S. Ergun Vascular wall resident progenitor cells: a source for postnatal vasculogenesis Development 133 2006 1543 1551 (Pubitemid 43732967)
10. J. Tillmanns, M. Rota, T. Hosoda, Y. Misao, G. Esposito, A. Gonzalez, S. Vitale, C. Parolin, S. Yasuzawa-Amano, and J. Muraski Formation of large coronary arteries by cardiac progenitor cells Proc Natl Acad Sci USA 105 2008 1668 1673 (Pubitemid 351346572)
11. C. Qian, R.G. Schoemaker, W.H. van Gilst, B. Yu, and A.J.M. Roks Regenerative cell therapy and pharmacotherapeutic intervention in heart failure. Part I: cardiovascular progenitor cells, their functions and sources Neth Heart J 16 2008 305 309
12. M. Prokopi, G. Pula, U. Mayr, C. Devue, J. Gallagher, Q. Xiao, C.M. Boulanger, N. Westwood, C. Urbich, and J. Willeit Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures Blood 114 2009 723 732
13. A.L. Ramos, R. Darabi, N. Akbarloo, L. Borges, J. Catanese, S.P. Dineen, R.A. Brekken, and R.C. Perlingeiro Clonal analysis reveals a common progenitor for endothelial. myeloid, and lymphoid precursors in umbilical cord blood Circ Res 107 2010 1460 1469
14. H. Kim, H.J. Cho, S.W. Kim, B. Liu, Y.J. Choi, J. Lee, Y.D. Sohn, M.Y. Lee, M.A. Houge, and Y.S. Yoon CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease Circ Res 107 2010 602 614
15. S.W. Kim, H. Kim, H.J. Cho, J.U. Lee, R. Levit, and Y.S. Yoon Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease J Am Coll Cardiol 56 2010 593 607
16. J. Hur, C.H. Yoon, H.S. Kim, J.H. Choi, H.J. Kang, K.K. Hwang, B.H. Oh, M.M. Lee, and Y.B. Park Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis Arterioscler Thromb Vasc Biol 24 2004 288 293 (Pubitemid 38197580)
17. R. Gulati, D. Jevremovic, T.E. Peterson, S. Chatterjee, V. Shah, R.G. Vile, and R.D. Simari Diverse origin and function of cells with endothelial phenotype obtained from adult human blood Circ Res 93 2003 1023 1025 (Pubitemid 37485031)
18. J.M. Hill, G. Zalos, J.P. Halcox, W.H. Schenke, M.A. Waclawiw, A.A. Quyyumi, and T. Finkel Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Eng J Med 348 2003 593 600 (Pubitemid 36204953)
19. Y. Lin, D.J. Weisdorf, A. Solovey, and R.P. Hebbel Origins of circulating endothelial cells and endothelial outgrowth from blood J Clin Invest 105 2000 71 77 (Pubitemid 30036389)
20. M.C. Yoder, L.E. Mead, D. Prater, T.R. Krier, K.N. Mroueh, F. Li, R. Krasich, C.J. Temm, J.T. Prchal, and D.A. Ingram Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood 109 2007 1801 1809 (Pubitemid 46348173)
21. A.A. Sirker, Z.M. Astroulakis, and J.M. Hill Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult Clin Sci (Lond) 116 2009 283 299
22. C. Clapp, S. Thebault, M.C. Jeziorski, and G. Martinez De La Escalera Peptide hormone regulation of angiogenesis Physiol Rev 89 2009 1177 1215
23. F.H. Bahlmann, K. de Groot, O. Mueller, B. Hertel, H. Haller, and D. Fliser Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists Hypertension 45 2005 526 529 First human study to show ARB effects. Chronic treatment of DMII patients with olmesartan increased blood-derived, adherent cultured VRPC as compared to placebo. Blood CD34+ cells did not change. Similar effects were seen with irbesartan. (Pubitemid 40411254)
24. H. Reinhard, P.K. Jacobsen, M. Lajer, N. Pedersen, N. Billestrup, T. Mandrup-Poulsen, H.H. Parving, and P. Rossing Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes Diabetologia 53 2010 2129 2133
25. F. Pelliccia, V. Pasceri, C. Cianfrocca, C. Vitale, G. Speciale, C. Gaudio, G.M. Rosano, and G. Mercuro Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study Atherosclerosis 210 2010 510 515 Randomized, double blind, placebo-controlled study that analyses the effect of telmisartan in patients with coronary artery disease on various blood VRPC by means of comprehensive flow cytometry. Telmisartan increased most of the VRPC. Notably, this was accompanied by improved vasodilator function of the brachial artery.
26. I. Porto, L. Di Vito, G.L. De Maria, I. Dato, A. Tritarelli, A.M. Leone, G. Niccoli, M.C. Capogrossi, L.M. Biasucci, and F. Crea Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-reactive protein and endothelial progenitor cells after acute coronary syndrome Am J Cardiol 103 2009 1500 1505
27. M. Steinmetz, C. Brouwers, G. Nickenig, and S. Wassmann Synergistic effects of telmisartan and simvastatin on endothelial progenitor cells J Cell Mol Med 14 2010 1645 1656
28. A. Honda, K. Matsuura, N. Fukushima, Y. Tsurumi, H. Kasanuki, and N. Hagiwara Telmisartan induces proliferation of human endothelial progenitor cells via PPARgamma-dependent PI3K/Akt pathway Atherosclerosis 205 2009 376 384 First study to show that telmisartan stimulates human VRPC proliferation through PPARγ, a process that involves PI3K/Akt and p21 signaling.
29. D.V. Erbe, K. Gartrell, Y.L. Zhang, V. Suri, S.J. Kirincich, S. Will, M. Perreault, S. Wang, and J.F. Tobin Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists Vascul Pharmacol 45 2006 154 162 (Pubitemid 44716729)
30. N. Townamchai, K. Praditpornsilpa, and S. Eiam-Ong Endothelial progenitor cells in Asian kidney transplant patients Transplant Proc 42 2010 1690 1694
31. Y. Yu, N. Fukuda, E.H. Yao, T. Matsumoto, N. Kobayashi, R. Suzuki, Y. Tahira, T. Ueno, and K. Matsumoto Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension Am J Hypertens 21 2008 72 77
32. Y. Yoshida, N. Fukuda, A. Maeshima, C. Yamamoto, T. Matsumoto, T. Ueno, Y. Nojima, K. Matsumoto, and M. Soma Treatment with valsartan stimulates endothelial progenitor cells and renal label-retaining cells in hypertensive rats J Hypertens 29 2011 91 101
33. D. You, C. Cochain, C. Loinard, J. Vilar, B. Mees, M. Duriez, B.I. Levy, and J.S. Silvestre Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents Hypertension 51 2008 1537 1544
34. R.A. Benndorf, D. Appel, R. Maas, E. Schwedhelm, U.O. Wenzel, and R.H. Boger Telmisartan improves endothelial function in patients with essential hypertension J Cardiovasc Pharmacol 50 2007 367 371
35. N. Werner, S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, A. Link, M. Bohm, and G. Nickenig Circulating endothelial progenitor cells and cardiovascular outcomes N Engl J Med 353 2005 999 1007 (Pubitemid 41262334)
36. S. Steiner, W.C. Winkelmayer, J. Kleinert, J. Grisar, D. Seidinger, C.W. Kopp, B. Watschinger, E. Minar, W.H. Horl, and M. Fodinger Endothelial progenitor cells in kidney transplant recipients Transplantation 81 2006 599 606
37. K. Hiasa, M. Ishibashi, K. Ohtani, S. Inoue, Q. Zhao, S. Kitamoto, M. Sata, T. Ichiki, A. Takeshita, and K. Egashira Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization Circulation 109 2004 2454 2461 (Pubitemid 38679567)
38. G. Salguero, E. Akin, C. Templin, D. Kotlarz, C. Doerries, U. Landmesser, K. Grote, and B. Schieffer Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner J Hypertens 26 2008 257 268 This comprehensive study provides in vivo evidence for the involvement of NAPDH oxidase in the Ang II effects on VRPC. 2K1C induction of renovascular hypertension increased blood VRPC in wild-type but not in p47phox4 knockout mice. VRPC in wild-type mice were lowered by RAS blockade or blood pressure lowering. SDF-1 and MMP9 might be involved in VRPC recruitment.
39. T. Yin, X. Ma, L. Zhao, K. Cheng, and H. Wang Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells Cell Res 18 2008 792 799 (Pubitemid 351948226)
40. T. Imanishi, T. Hano, and I. Nishio Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells Hypertens Res 27 2004 101 108 First study to show that stimulatory Ang II effects on VRPC depend on improvement of VEGF function. (Pubitemid 38331920)
41. K. Ohtani, K. Egashira, Y. Ihara, K. Nakano, K. Funakoshi, G. Zhao, M. Sata, and K. Sunagawa Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells Hypertension 48 2006 664 670 (Pubitemid 44843870)
42. F. Sanada, Y. Taniyama, J. Azuma, K. Iekushi, N. Dosaka, T. Yokoi, N. Koibuchi, H. Kusunoki, Y. Aizawa, and R. Morishita Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence Hypertension 53 2009 77 82
43. J.S. Silvestre, R. Tamarat, T. Senbonmatsu, T. Icchiki, T. Ebrahimian, M. Iglarz, S. Besnard, M. Duriez, T. Inagami, and B.I. Levy Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb Circ Res 90 2002 1072 1079 (Pubitemid 34627905)
44. R. Benndorf, R.H. Boger, S. Ergun, A. Steenpass, and T. Wieland Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells Circ Res 93 2003 438 447 (Pubitemid 37100009)
45. D. Iusuf, R.H. Henning, W.H. van Gilst, and A.J. Roks Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives Eur J Pharmacol 585 2008 303 312
46. M. Vasa, S. Fichtlscherer, A. Aicher, K. Adler, C. Urbich, H. Martin, A.M. Zeiher, and S. Dimmeler Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circ Res 89 2001 E1 7
47. T.Q. Min, C.J. Zhu, W.X. Xiang, Z.J. Hui, and S.Y. Peng Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease Cardiovasc Drugs Ther 18 2004 203 209 (Pubitemid 38918955)
48. P. Muller, A. Kazakov, P. Jagoda, A. Semenov, M. Bohm, and U. Laufs ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload Cardiovasc Res 83 2009 106 114
49. C.H. Wang, S. Verma, I.C. Hsieh, Y.J. Chen, L.T. Kuo, N.I. Yang, S.Y. Wang, M.Y. Wu, C.M. Hsu, and C.W. Cheng Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system J Mol Cell Cardiol 41 2006 34 43 (Pubitemid 43946959)
50. D. You, C. Cochain, C. Loinard, J. Vilar, B. Mees, M. Duriez, B.I. Levy, and J.S. Silvestre Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats J Pharmacol Exp Ther 325 2008 766 773 In this study, the effects of a 2-week treatment with ACEi (perindoprilat), ARB (losartan), ROS-scavenger N-acetyl-l-cysteine (NAC), a diuretic (hydralazine), and BM-MNC infusion are tested on vasculogenesis after femoral artery ligature in Wistar Kyoto rats (WKY) or spontaneously hypertensive rats (SHR). All treatments restored reduced vessel growth in SHR to WKY levels, reduced BM-MNC ROS levels, and increased cultured adherent VRPC. Effects on blood c-Kit+/CD34+ VRPC varied, depending on treatment and presence of hindlimb ischemia. (Pubitemid 351724312)
51. T. Thum, D. Fraccarollo, P. Galuppo, D. Tsikas, S. Frantz, G. Ertl, and J. Bauersachs Bone marrow molecular alterations after myocardial infarction: impact on endothelial progenitor cells Cardiovasc Res 70 2006 50 60 Comparison of 3-day and 10-week ACEi and statin on adherent, cultured acLDL+/UEA-1+/ VEGFR2+/eNOS+ VRPC levels, featured by comprehensive functional studies. 3-days post MI VRPC levels and CFU formation were reduced by ∼40 and 30% resp.BM p-ERK, MMP-9 activity were diminished, but ROS levels increased. ACEi treatment increased VRPC levels, p-ERK, and MMP-9 activity. Statin therapy enhanced BM VEGF levels, and eNOS activity, and normalized ROS levels. The treatment effects on VRPC number associated with improved cardiac function and increased capillary density in the peri-infarct area 7 days post-MI, and were sustained for 10 weeks.
52. K.E. Rodgers, S. Xiong, R. Steer, and G.S. diZerega Effect of angiotensin II on hematopoietic progenitor cell proliferation Stem Cells 18 2000 287 294 (Pubitemid 30602276)
53. S. Heringer-Walther, K. Eckert, S.M. Schumacher, L. Uharek, A. Wulf-Goldenberg, F. Gembardt, I. Fichtner, H.P. Schultheiss, K. Rodgers, and T. Walther Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo Haematologica 94 2009 857 860
54. M. Mrug, T. Stopka, B.A. Julian, J.F. Prchal, and J.T. Prchal Angiotensin II stimulates proliferation of normal early erythroid progenitors J Clin Invest 100 1997 2310 2314 (Pubitemid 27500154)
55. C. Peng, W.M. Li, Y.P. Ma, Z.B. Hu, F.J. Cheng, L.B. Liu, and P. Zou Effect of angiotensin II on cord blood CD34(+) cells expansion in vitro Zhongguo Shi Yan Xue Ye Xue Za Zhi 11 2003 227 229
56. K.E. Rodgers, S. Xiong, and G.S. diZerega Accelerated recovery from irradiation injury by angiotensin peptides Cancer Chemother Pharmacol 49 2002 403 411 (Pubitemid 34439342)
57. K.E. Rodgers, S. Xiong, and G.S. diZerega Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy Cancer Chemother Pharmacol 51 2003 97 106 (Pubitemid 36259469)
58. J.E. Chisi, J. Wdzieczak-Bakala, J. Thierry, C.V. Briscoe, and A.C. Riches Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures Stem Cells 17 1999 339 344
59. J. Cole, D. Ertoy, H. Lin, R.L. Sutliff, E. Ezan, T.T. Guyene, M. Capecchi, P. Corvol, and K.E. Bernstein Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice J Clin Invest 106 2000 1391 1398
60. D.D. Ellefson, G.S. diZerega, T. Espinoza, N. Roda, S. Maldonado, and K.E. Rodgers Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice Cancer Chemother Pharmacol 53 2004 15 24 (Pubitemid 38161184)
61. K.E. Rodgers, J. Oliver, and G.S. diZerega Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer Cancer Chemother Pharmacol 57 2006 559 568 (Pubitemid 43237839)
62. Y. Wang, C. Qian, A.J. Roks, D. Westermann, S.M. Schumacher, F. Escher, R.G. Schoemaker, T.L. Reudelhuber, W.H. van Gilst, and H.P. Schultheiss Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction Circ Heart Fail 3 2010 286 293 First study to show the proliferative effect of Ang-(1-7) on VRPC. Effects were measured in cultured adherent rat and mouse VRPC derived from bone marrow. Mas receptor antagonist A779 or Mas receptor knockout abolished the responses to Ang-(1-7).
63. B. Langeveld, W.H. van Gilst, R.A. Tio, F. Zijlstra, and A.J. Roks Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat Hypertension 45 2005 138 141 (Pubitemid 40066428)
64. A.E. Loot, A.J. Roks, R.H. Henning, R.A. Tio, A.J. Suurmeijer, F. Boomsma, and W.H. van Gilst Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats Circulation 105 2002 1548 1550 (Pubitemid 34297630)
65. B.E. Langeveld, R.H. Henning, B.J. de Smet, F. Zijlstra, A. Driessen, E. Tijsma, W.H. van Gilst, and A. Roks Rescue of arterial function by angiotensin-(1-7): towards improvement of endothelial function by drug-eluting stents Neth Heart J 16 2008 291 292
66. W.O. Sampaio, R.A. Souza dos Santos, R. Faria-Silva, L.T. da Mata Machado, E.L. Schiffrin, and R.M. Touyz Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways Hypertension 49 2007 185 192 (Pubitemid 46360359)
67. W.O. Sampaio, C. Henrique de Castro, R.A. Santos, E.L. Schiffrin, and R.M. Touyz Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells Hypertension 50 2007 1093 1098 (Pubitemid 350172931)
68. K.E. Rodgers, N. Roda, J.E. Felix, T. Espinoza, S. Maldonado, and G. diZerega Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice Exp Dermatol 12 2003 784 790 (Pubitemid 38035076)
69. H.M. van Beusekom, R. Schoemaker, A.J. Roks, F. Zijlstra, and W.J. van der Giessen Coronary stent healing, endothelialisation and the role of co-medication Neth Heart J 15 2007 395 396 (Pubitemid 350206883)
70. R.D. Machado, R.A. Santos, and S.P. Andrade Opposing actions of angiotensins on angiogenesis Life Sci 66 2000 67 76 (Pubitemid 30025450)
71. L. Anton, D.C. Merrill, L.A. Neves, and K.B. Brosnihan Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor Endocrine 32 2007 212 218
72. A.M. Garrido, and K.K. Griendling NADPH oxidases and angiotensin II receptor signaling Mol Cell Endocrinol 302 2009 148 158
73. B. Assmus, C. Urbich, A. Aicher, W.K. Hofmann, J. Haendeler, L. Rossig, I. Spyridopoulos, A.M. Zeiher, and S. Dimmeler HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes Circ Res 92 2003 1049 1055 (Pubitemid 36588505)
74. I. Ben Porath, and R.A. Weinberg The signals and pathways activating cellular senescence Int J Biochem Cell Biol 37 2005 961 976 (Pubitemid 40311739)
75. D.A. Freedman, and J. Folkman CDK2 translational down-regulation during endothelial senescence Exp Cell Res 307 2005 118 130 (Pubitemid 40732738)
76. G.P. Dimri, X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E.E. Medrano, M. Linskens, I. Rubelj, and O. Pereira-Smith A biomarker that identifies senescent human cells in culture and in aging skin in vivo Proc Natl Acad Sci USA 92 1995 9363 9367
77. T. Minamino, and I. Komuro Vascular cell senescence: contribution to atherosclerosis Circ Res 100 2007 15 26 (Pubitemid 46074968)
78. H. Oeseburg, D. Iusuf, P. van der Harst, W.H. van Gilst, R.H. Henning, and A.J. Roks Bradykinin protects against oxidative stress-induced endothelial cell senescence Hypertension 53 2009 417 422
79. J.J. Fuster, and V. Andres Telomere biology and cardiovascular disease Circ Res 99 2006 1167 1180 (Pubitemid 44808653)
80. K. Kobayashi, T. Imanishi, and T. Akasaka Endothelial progenitor cell differentiation and senescence in an angiotensin II-infusion rat model Hypertens Res 29 2006 449 455 (Pubitemid 44102813)
81. T. Imanishi, T. Hano, and I. Nishio Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress J Hypertens 23 2005 97 104 First study to show induction of VRPC senescence by Ang II. (Pubitemid 40128986)
82. L. Rossig, A.S. Jadidi, C. Urbich, C. Badorff, A.M. Zeiher, and S. Dimmeler Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells Mol Cell Biol 21 2001 5644 5657 (Pubitemid 32702467)
83. T. Imanishi, K. Kobayashi, A. Kuroi, H. Ikejima, and T. Akasaka Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell Hypertens Res 31 2008 757 765 (Pubitemid 351772867)
84. Z. Zhou, J. Peng, C.J. Wang, D. Li, T.T. Li, C.P. Hu, X.P. Chen, and Y.J. Li Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide J Hypertens 28 2010 931 939
85. Z. Zhou, C.P. Hu, C.J. Wang, T.T. Li, J. Peng, and Y.J. Li Calcitonin gene-related peptide inhibits angiotensin II-induced endothelial progenitor cells senescence through up-regulation of klotho expression Atherosclerosis 213 2010 92 101